Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 3
2005 4
2006 3
2007 3
2008 4
2009 1
2010 5
2011 6
2012 5
2013 5
2014 4
2015 5
2016 3
2017 10
2018 11
2019 10
2020 9
2021 8
2022 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Quantitative analysis of endogenous compounds.
Thakare R, Chhonker YS, Gautam N, Alamoudi JA, Alnouti Y. Thakare R, et al. Among authors: alnouti y. J Pharm Biomed Anal. 2016 Sep 5;128:426-437. doi: 10.1016/j.jpba.2016.06.017. Epub 2016 Jun 11. J Pharm Biomed Anal. 2016. PMID: 27344632 Review.
ProTide generated long-acting abacavir nanoformulations.
Lin Z , Gautam N , Alnouti Y , McMillan J , Bade AN , Gendelman HE , Edagwa B . Lin Z , et al. Among authors: alnouti y. Chem Commun (Camb). 2018 Jul 24;54(60):8371-8374. doi: 10.1039/c8cc04708a. Chem Commun (Camb). 2018. PMID: 29995046 Free PMC article.
Creation of a long-acting nanoformulated dolutegravir.
Sillman B, Bade AN, Dash PK, Bhargavan B, Kocher T, Mathews S, Su H, Kanmogne GD, Poluektova LY, Gorantla S, McMillan J, Gautam N, Alnouti Y, Edagwa B, Gendelman HE. Sillman B, et al. Among authors: alnouti y. Nat Commun. 2018 Feb 6;9(1):443. doi: 10.1038/s41467-018-02885-x. Nat Commun. 2018. PMID: 29402886 Free PMC article.
A long acting nanoformulated lamivudine ProTide.
Smith N, Bade AN, Soni D, Gautam N, Alnouti Y, Herskovitz J, Ibrahim IM, Wojtkiewicz MS, Dyavar Shetty BL, McMillan J, Gendelman HE, Edagwa B. Smith N, et al. Among authors: alnouti y. Biomaterials. 2019 Dec;223:119476. doi: 10.1016/j.biomaterials.2019.119476. Epub 2019 Sep 5. Biomaterials. 2019. PMID: 31525692 Free PMC article.
Creation of a Long-Acting Nanoformulated 2',3'-Dideoxy-3'-Thiacytidine.
Guo D, Zhou T, Araínga M, Palandri D, Gautam N, Bronich T, Alnouti Y, McMillan J, Edagwa B, Gendelman HE. Guo D, et al. Among authors: alnouti y. J Acquir Immune Defic Syndr. 2017 Mar 1;74(3):e75-e83. doi: 10.1097/QAI.0000000000001170. J Acquir Immune Defic Syndr. 2017. PMID: 27559685 Free PMC article.
A year-long extended release nanoformulated cabotegravir prodrug.
Kulkarni TA, Bade AN, Sillman B, Shetty BLD, Wojtkiewicz MS, Gautam N, Hilaire JR, Sravanam S, Szlachetka A, Lamberty BG, Morsey BM, Fox HS, Alnouti Y, McMillan JM, Mosley RL, Meza J, Domanico PL, Yue TY, Moore G, Edagwa BJ, Gendelman HE. Kulkarni TA, et al. Among authors: alnouti y. Nat Mater. 2020 Aug;19(8):910-920. doi: 10.1038/s41563-020-0674-z. Epub 2020 Apr 27. Nat Mater. 2020. PMID: 32341511 Free PMC article.
Synthesis and Characterization of Long-Acting Darunavir Prodrugs.
Banoub MG, Bade AN, Lin Z, Cobb D, Gautam N, Dyavar Shetty BL, Wojtkiewicz M, Alnouti Y, McMillan J, Gendelman HE, Edagwa B. Banoub MG, et al. Among authors: alnouti y. Mol Pharm. 2020 Jan 6;17(1):155-166. doi: 10.1021/acs.molpharmaceut.9b00871. Epub 2019 Dec 3. Mol Pharm. 2020. PMID: 31742407 Free PMC article.
Creation of a long-acting rilpivirine prodrug nanoformulation.
Hilaire JR, Bade AN, Sillman B, Gautam N, Herskovitz J, Dyavar Shetty BL, Wojtkiewicz MS, Szlachetka A, Lamberty BG, Sravanam S, Fox HS, Alnouti Y, Dash PK, McMillan JM, Edagwa BJ, Gendelman HE. Hilaire JR, et al. Among authors: alnouti y. J Control Release. 2019 Oct;311-312:201-211. doi: 10.1016/j.jconrel.2019.09.001. Epub 2019 Sep 3. J Control Release. 2019. PMID: 31491432 Free PMC article.
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation.
Deodhar S, Sillman B, Bade AN, Avedissian SN, Podany AT, McMillan JM, Gautam N, Hanson B, Dyavar Shetty BL, Szlachetka A, Johnston M, Thurman M, Munt DJ, Dash AK, Markovic M, Dahan A, Alnouti Y, Yazdi A, Kevadiya BD, Byrareddy SN, Cohen SM, Edagwa B, Gendelman HE. Deodhar S, et al. Among authors: alnouti y. Nat Commun. 2022 Jun 9;13(1):3226. doi: 10.1038/s41467-022-30902-7. Nat Commun. 2022. PMID: 35680875 Free PMC article.
93 results